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Background: Jaagsiekte sheep retrovirus (JSRV) is the causative agent of ovine pulmonary adenocarcinoma (OPA), a
transmissible neoplastic disease of sheep. OPA is an economically important veterinary disease and is also a valuable
naturally occurring animal model of human lung cancer, with which it shares a similar histological appearance and the
activation of common cell signaling pathways. Interestingly, the JSRV Env protein is directly oncogenic and capable of
driving cellular transformation in vivo and in vitro. Previous studies of JSRV infection in cell culture have been hindered
by the lack of a permissive cell line for the virus. Here, we investigated the ability of JSRV to infect slices of ovine lung
tissue cultured ex vivo.
Results: We describe the use of precision cut lung slices from healthy sheep to study JSRV infection and transformation
ex vivo. Following optimization of the culture system we characterized JSRV infection of lung slices and compared the
phenotype of infected cells to natural field cases and to experimentally-induced OPA tumors from sheep. JSRV was able
to infect cells within lung slices, to produce new infectious virions and induce cell proliferation. Immunohistochemical
labeling revealed that infected lung slice cells express markers of type II pneumocytes and phosphorylated Akt and
ERK1/2. These features closely resemble the phenotype of natural and experimentally-derived OPA in sheep, indicating
that lung slice culture provides an authentic ex vivo model of OPA.
Conclusions: We conclude that we have established an ex vivo model of JSRV infection. This model will be valuable
for future studies of JSRV replication and early events in oncogenesis and provides a novel platform for studies of
JSRV-induced lung cancer.
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Lung cancer is the leading cause of cancer deaths world-
wide, causing over 1.6 million deaths in 2012 [1]. Patients
with lung cancer typically do not present with symp-
toms until the tumor is well established and has
already metastasized, which contributes to the low sur-
vival rate [2]. Greater understanding of the molecular
and cellular basis of lung cancer is required to drive
improvements in prevention, diagnosis, prognosis and
treatment. Animal models of lung cancer, especially in
mice have provided a wealth of information on the
molecular basis of cancer (reviewed by [3]). However,
murine models do not fully mimic the physiology of* Correspondence: chris.cousens@moredun.ac.uk
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unless otherwise stated.the human lung and alternative animal species may
offer novel insights into pulmonary biology. For ex-
ample, the sheep has been suggested to offer advan-
tages over murine models due to the closer anatomical
similarity to human lungs with respect to size and
structure [4].
Ovine pulmonary adenocarcinoma (OPA; also known as
jaagsiekte) is a common lung cancer of sheep caused by
Jaagsiekte sheep retrovirus (JSRV) (reviewed by [5-7]).
OPA is an economically important disease of sheep in
many countries and has also been proposed as a model of
human lung cancer; in particular for relatively non-invasive
forms such as lepidic-predominant adenocarcinoma (for-
merly bronchioloalveolar carcinoma) [8]. Although OPA
has a known viral etiology [9], no infectious cause has been
found for human lung cancer [10]. Nevertheless, OPA
represents an important model system that providesl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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genesis and to develop methods for early diagnosis. Not-
ably, experimental reproduction of OPA can be achieved
by infection of young lambs with JSRV harvested from
OPA-affected animals or by virus produced in vitro using
an infectious molecular clone [9,11,12]. This experimental
system provides an excellent disease model for studying
OPA pathogenesis.
The mechanism of oncogenesis by JSRV has been the
subject of a number of studies (reviewed by [13]), which
have demonstrated that the envelope (Env) protein of
JSRV is oncogenic and expression of Env alone is suffi-
cient to transform cell lines in vitro [14,15] and to in-
duce tumors in immunosuppressed mice or in lambs
[16,17]. In studies aimed at examining early events in
JSRV infection and transformation, JSRV-infected cells
have been characterized in experimentally infected lambs
10 days after infection [18,19]. However, performing
such studies in vivo is very laborious due to the difficulty
of finding the small number of JSRV-infected cells in the
ovine lung so soon after infection [18].
In vivo reproduction of OPA, of course, has cost and
ethical implications and where possible replacement
with appropriate in vitro systems is desirable. However,
analysis of JSRV infection and transformation in vitro
has been hindered by the lack of a permissive cell line
that can support efficient JSRV replication. In vivo, JSRV
is known to infect a number of diverse cell types, includ-
ing epithelial cells in the lung and myeloid and lymphoid
cells in the lymphoreticular system [20,21]. However, if
replication of the virus in lymphocytes and monocyte/
macrophages occurs, it is at a very low level as JSRV
protein expression in these cells has been detected only
rarely. In the sheep lung, JSRV is known to predomin-
antly infect proliferating type II pneumocytes [19] and,
to a lesser extent, club cells [18,22] (formerly known as
Clara cells [23]) but these cell types do not maintain
their differentiated state in culture unless grown in 3D
culture systems such as matrigel matrix and transwell
dishes [24-26], which reflects the importance of pola-
rization for maintaining epithelial cell phenotype. A sys-
tem that can support JSRV replication in vitro would
greatly benefit studies on OPA pathogenesis.
Here, we describe the use of precision-cut lung slices
from healthy sheep to study JSRV infection and trans-
formation ex vivo. This system allows the maintenance
of type II pneumocytes and other pulmonary cell types
in culture and, because the tissue architecture and diver-
sity of cell types are maintained, provides a more au-
thentic representation of the in vivo lung than cell lines
grown as monolayers or in 3D matrices [27,28]. Follow-
ing optimization of the culture system we demonstrated
that JSRV replicates in ovine lung slices and that the
phenotype of infected cells reproduces those observed innatural field cases of OPA (OPA-N) and in vivo
experimentally-induced OPA (OPA-E) tumors. These
data confirm lung slice culture as an authentic in vitro
system for studying early events in JSRV infection and
pulmonary cell transformation.Results
Establishment of an ovine lung slice culture system
Precision-cut lung slices were prepared from normal
healthy ovine lungs using a procedure similar to those
that have been used successfully in other species [27].
Although lung slice cultures provide a closer in vitro
model of the lung than monolayer cultures [28], ex vivo
culture is nevertheless likely to have significant effects
on the tissue and therefore the first question addressed
was how the lung slices change over time in culture.
The viability of the lung slices, as judged by visible cil-
iary activity was maintained for at least 21 days. Cell via-
bility was also assessed by staining the cytoplasm of live
cells with a green fluorescent dye, and the nuclei of
membrane-compromised cells with a red fluorescent
dye. This confirmed that during the first week in cul-
ture most cells in the lung slices were alive although
dead cells were evident around the peripheral cut sur-
faces (data not shown). Subsequently, the number of
dead cells increased but the background yellow/green
autofluorescence of the lung slices also increased so it
became difficult to visualize the live/dead staining
after 2–3 weeks in culture despite visible ciliary
activity.
Morphological changes due to hyper-cellularity were
noticeable from around day 8 in culture, and were par-
ticularly marked around the cut edges of the slices
(Figure 1A, B). Similar gross changes were seen both in
JSRV-infected or uninfected lung slices demonstrating
that the aberrant growth was not due to JSRV infection
but instead appears to be a reaction of the tissue to pro-
cessing and/or in vitro culture. After an extended time
in culture (42 days) the epithelial cells continued to ap-
pear histologically normal whereas interstitial cells ap-
peared degenerate (Figure 1C). IHC labeling with an
antibody to the proliferation marker Ki-67 suggested
that the structural changes in the first weeks of culture
were due to proliferation of cells in the interstitial com-
partment (Figure 1D). There was also an increase in cu-
boidal cells lining the alveoli which were positive for
pan-cytokeratin (an epithelial cell marker) (Figure 1E)
and DC-LAMP (type II pneumocytes) (Figure 1F), indi-
cative of type II pneumocyte hyperplasia, which may be
a response of the tissue to injury caused by slicing. This
analysis indicated that ovine lung slices can survive in
culture for at least 6 weeks whilst retaining many of the
characteristics of normal lung tissue.
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Figure 1 Viability and structure of cultured ovine lung slices. Hematoxylin and eosin (HE) stained uninfected lung slices at 0 (A), 16 (B) and
42 (C) dpi. In panel B the arrows indicate areas of “thickening” around the edges of the lung slice. In panel C the small arrow indicates epithelial
cells and the large arrow indicates necrotic interstitial cells. D, E, F) IHC of d16 lung slices labeled with anti-Ki-67 (D), anti-pan-cytokeratin (E), and
anti-DC-LAMP (F). Lung slices D, E and F were treated with the replication-defective JSRV-ΔRT virus.
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Figure 2 Detection of JSRV RNA in lung slice supernatants
indicates replication of JSRV. JSRV was added to lung slices and
medium changed daily. The results show JSRV RNA content of 24 h
supernatants (pooled from 4 wells) presented as a percentage of the
inoculum (100%) for lung slices prepared from 6 animals of a range
of ages; 9 months old (1 J and 2 J), 10 years old (3 J), 2 years old
(4 J), and 5 days old (5 J and 6 J). Results for the equivalent JSRV-
ΔRT-treated lung slices are not shown as these were all negative
after day 4. Control lung slices to which no JSRV was added were
negative throughout. The results shown here are for the lung slices
from the same experiments that provided the lung slices for
serial sections.
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We next determined whether JSRV can infect and repli-
cate in cultured ovine lung slices. Lung slices were pre-
pared and JSRV was added to the culture medium. At 4,
8, 12 and 16 days post infection (dpi) the supernatant
(culture medium) was harvested and analyzed for the
presence of JSRV RNA by RT-qPCR. Negative controls
included uninfected lung slices and lung slices infected
with a replication-defective JSRV mutant that carries an
inactivating mutation in the active site of reverse tran-
scriptase (JSRV-ΔRT). Slices of lung tumor prepared
from OPA-N lung were used as positive controls.
Culture supernatants from wells containing tissue slices
of OPA-N were always strongly positive (Ct 20–24) by RT-
qPCR for JSRV RNA, while supernatants from wells con-
taining uninfected lung slices were always negative. RNA
from replication-defective JSRV-ΔRT was detectable at low
levels (0.01-0.1% of inoculum) in lung slice supernatant up
to 4 dpi. This most likely results from residual input virus
that has non-specifically bound to the lung slices or the
culture plate. Thereafter, the supernatants of JSRV-ΔRT-
treated lung slices were consistently negative by JSRV RT-
qPCR, indicating that residual input virus was not present
in samples taken at 8 dpi and later. In contrast, JSRV RNA
was readily detected in the supernatant of JSRV-infected
lung slices from 4 or 8 dpi and the concentration increased
further towards 12 and 16 dpi (Figure 2). However, there
was large variability in the quantity of virus detected in the
supernatant between experiments (i.e., using lung slices
sourced from different animals) despite the use of a stan-
dardized infection and analysis protocol.We then examined JSRV-infected lung slices by IHC
using an antibody to the JSRV Env (SU) protein [29].
Foci of SU-positive cells were detectable from 4 dpi on-
wards (Figure 3A-F), but the number of positive cells
per section was highly variable even within a single experi-
ment (i.e., replicate lung slices from a single donor animal)
and the proportion of positive sections varied between ex-
periments (i.e., lung slices from different donor animals).
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Figure 3 JSRV-infected lung slice and early experimental OPA show a similar pattern of JSRV-SU labeling. Sections of JSRV-infected tissue
were labeled with a monoclonal antibody to JSRV Env (SU) by IHC. Positive labeling is shown by brown pigment. A, B) JSRV-infected lung slice 8
dpi; C, D) JSRV-infected lung slice 16 dpi; E, F) Lung tissue from lambs experimentally infected with JSRV 10 dpi; G, H) Lung slices infected with
control virus JSRV-ΔRT 16 dpi showed no labeling. I, J) Lung slices infected with pooled supernatant of previous JSRV-infected lung slices 12 dpi.
K, L) Lung slices infected with pooled supernatant of previous JSRV-ΔRT infected lung slices 12 dpi. Dashed circles in A, C, E, G, I and K indicate
the regions shown at higher magnification in B, D, F, H, J and L, respectively.
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8 dpi only 1 group of SU-positive cells was detected from
sections of 4 replicate lung slices whereas at 12 or 16 dpi
two or three groups of cells expressing JSRV SU were vis-
ible in the sections of 3 of the 4 lung slice replicates. The
histological appearance of clusters of labeled cells in JSRV-
infected lung slices (Figure 3A-D) was indistinguishable
from early nodules in OPA-E (Figure 3E-F). SU-labeling of
cells was localized in the cytoplasm and at the cell surface
with stronger labeling at the apical pole. SU-labeling was
not seen in any of the uninfected lung slices nor in JSRV-
ΔRT-treated lung slices (Figure 3G, H), thus confirming
the specificity of the anti-SU antibody in IHC.
The RT-qPCR and IHC data indicate that JSRV can in-
fect cells in ovine lung slices and express viral proteins
and release viral particles. We next asked whether the
JSRV released by infected lung slices is also infectious.
Supernatants from JSRV-infected and JSRV-ΔRT-treated
lung slices were harvested and used to infect new lung
slice cultures. The supernatants from JSRV-infected lung
slices, but not JSRV-ΔRT-treated lung slices, gave rise to
JSRV-positive cells as shown by IHC for SU (Figure 3I-L).
These results confirm that JSRV produced by lung slice
cultures is infectious. Together, these data indicate that
JSRV is able to infect and replicate in ovine lung slicescultured in vitro thereby providing a system to examine
early events following infection.
JSRV infects type 2 pneumocytes in ovine lung slices
The identity of cell types infected and transformed by
JSRV in OPA has attracted interest as these may also
represent the cells of origin of other lung cancers. We
therefore examined the phenotype of JSRV-infected cells
within cultured lung slices using IHC on serial adjacent
sections labeled with the anti-JSRV SU antibody and
antibodies to respiratory epithelial cellular markers
(Table 1, Figures 4 and 5). A panel of six lung slices that
contained many SU-positive foci was selected for ana-
lysis. Sections of lung from OPA-N were analyzed in
parallel for comparison.
In the lung, cytokeratins are a marker for pulmonary
conducting and respiratory airway epithelial cells and
anti-pancytokeratin antibody labels the cells lining the
trachea, bronchi and bronchioles and pneumocytes. Using
IHC with an anti-pancytokeratin antibody, we found that
this also labeled tumor cells in OPA-N (Figure 4A). In
serial sections of JSRV-infected lung slices, cells labeling
with anti-pancytokeratin (Figure 4B) co-aligned with SU-
positive cells (Figure 4D) confirming that the JSRV-
infected cells in lung slices were of epithelial origin.
Table 1 Summary of antibodies used for IHC
Antibody target antigen Cell target Dilution Antibody type Source Positive control tissue
Cytokeratin Pan-respiratory
epithelia
1/5000 Mouse mab* DAKO M3515 normal sheep lung
JSRV Env (SU) JSRV-infected 1/800 2 Mouse mabs [16] OPA positive sheep lung
Club cell specific protein (CCSP) Club cell 1/20,000 Rabbit
polyclonal
[18,19] normal sheep lung
Dendritic cell lysosome-associated
membrane glycoprotein (DC-LAMP)
Type II pneumocytes 1/1,000 Rat mab Dendritics Clone
1010E1.01
normal sheep lung
Ki-67 Dividing cells 1/1,000 Mouse mab DAKO M7240 normal sheep lung
Phospho-ERK1/2 (Thr202/Tyr204) Activated ERK1/2 1/600 Rabbit mab Cell Signaling NEB
(UK) 4370S
normal sheep placenta
[62]
Phospho-Akt (Ser473) (D9E) Activated Akt 1/400 Rabbit mab Cell Signaling NEB
(UK) 4060S
normal sheep placenta
[62]
Normal rabbit serum Negative control matched to
primary
Rabbit
polyclonal
In house NA
Normal mouse IgG Negative control matched to
primary
Mouse Sigma I5381 NA
Normal rabbit IgG Negative control matched to
primary
Rabbit Sigma I5006 NA
*mab: monoclonal antibody NA: not applicable.
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in lung slices, we initially used an antibody to surfactant
protein C (SP-C), which is a specific marker of those cells.
Although this antibody is highly specific on ovine lung tis-
sue [18,30], it produced non-specific labeling on lung slicesC D
200µm500µm
A B
200µm200µm
Figure 4 IHC with anti-pancytokeratin antibody labels respiratory
epithelial cells and this co-localises with JSRV-positive tumor cells
in the lungs of OPA-positive sheep and JSRV-positive lung slice
cells. A) OPA-N; B, C, D) Serial adjacent sections of JSRV-infected
lung slice 16 dpi labeled with A, B) anti-pancytokeratin (respiratory
epithelium); C) rabbit IgG (IHC negative control); D) anti-SU
(JSRV-positive cells).(not shown). As an alternative, we used an antibody to
DC-LAMP (CD208), which has been shown previously to
be a marker of type II pneumocytes [31,32]. On OPA-N
lung tissue, DC-LAMP labeling was observed in the cyto-
plasm of type II pneumocytes and in OPA tumor cells
(Figure 5B). On the lung slices, anti-DC-LAMP labeled
cells in the expected anatomical locations and with a
morphology typical of type II pneumocytes (Figure 5H). In
addition, for JSRV-infected lung slices all 6 sets of serial
sections analyzed exhibited co-alignment of cells labeling
with anti-SU and cells with positive labeling for DC-LAMP
(Figure 5D, E). The DC-LAMP labeling observed was
granular and cytoplasmic varying from weak to intense.
In normal and OPA-N lung, an antibody recognizing
club cell-specific protein (CCSP) labeled the cytoplasm of
cells in the bronchiolar epithelium consistent with the
expected location and morphology of club cells (i.e.,
non-ciliated cells positioned between the ciliated cells)
(Figure 5C). CCSP-positive cells were not observed in
OPA-N tumor nodules (Figure 5C). In the lung slices, anti-
CCSP labeled club cells in the bronchiolar epithelium
(Figure 5L) but did not label SU-positive cells in any of the
JSRV-infected lung slices (Figure 5F). Taken together, the
IHC results indicate that JSRV-infected cells in lung slices
are of epithelial origin and express markers of type II pneu-
mocytes, which is the same as the phenotype of JSRV-
infected cells in OPA-N and OPA-E.Proliferation and transformation of JSRV-infected cells
Abnormally increased cell division is a fundamental trait
of cell transformation and tumor development [33,34].
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Figure 5 SU-positive cells in JSRV-infected lung slices are CCSP negative and DC-LAMP positive. Serial sections of A-C) OPA-N; D-F) JSRV-
infected lung slice,16 dpi and G-L) JSRV-ΔRT-infected lung slice 16 dpi were subjected to IHC for JSRV SU and for respiratory epithelial cell markers:
A, D, G, J) anti-JSRV SU; B, E, H, K) anti-DC-LAMP; C, F, I, L) anti-CCSP; Figure 5A and G/J show positive and negative controls, respectively, for JSRV
SU-labeling. Note areas of co-labeling with markers for OPA tumor cells and type II pneumocytes (A/B and D/E) but no co-labeling with the marker
for club cells (C and F).
Cousens et al. Retrovirology  (2015) 12:31 Page 6 of 16Therefore, we investigated whether increased cell div-
ision was associated with JSRV infection using an anti-
body to the proliferation marker Ki-67 (Figure 6). On
sections of OPA-N tissue, anti-Ki-67 was found to label
the nuclei of neutrophils and a moderate number of
endothelial cells and fibroblasts (not shown). In general,
only a small proportion (<10%) of OPA tumor cells were
labeled but in some tumor nodules a higher proportion
(>60%) of labeled cells was seen. For example, in theOPA nodule shown in Figure 6A-C approximately 5% of
tumor cells labeled with anti-Ki-67 whereas a different
OPA nodule from the same animal, shown in Figure 6D-
F, showed more than 50% of tumor cells labeled
positively for Ki-67. In JSRV-infected lung slices, the
majority of SU-positive cells were also Ki-67 positive
(Figure 6G, H) showing that a large number of the
JSRV-infected cells were proliferating. Indeed, at low
magnification SU-positive groups of cells could easily be
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Figure 6 Cell proliferation is increased in SU-positive cells in JSRV-infected lung slices and in some, but not all, OPA tumor nodules.
Serial sections were labeled with anti-JSRV SU (OPA tumor cells), anti-Ki-67 (proliferation marker), and with murine IgG (MoIgG) (negative control)
antibodies. A-F) OPA-N; G-K) JSRV-infected lung slice (16 dpi); L) JSRV-ΔRT-infected lung slice (16 dpi). Each scale bar is representative for the
whole row.
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whereas JSRV-ΔRT-infected lung slices did not show
similar areas of dense Ki-67 labeling (Figure 6L).
Studies in cell lines have identified that JSRV Env acti-
vates a number of cellular signaling pathways involved
in neoplastic transformation, including the Akt-mTOR
and Ras-Raf-MEK-ERK pathways (reviewed by [13]).
Phosphorylation of Akt or ERK1/2, respectively, are indi-
cative of activation of these signaling pathways. In order
to examine their activation in JSRV-infected lung slices,
IHC with antibodies against phospho-Akt (P-Akt) andphospho-ERK1/2 (P-ERK1/2) was employed after first
optimizing on ovine placental tissue (Table 1).
IHC on OPA-N indicated that 50-100% of OPA tumor
cells labeled positively with anti-P-Akt (nuclear and
cytoplasmic labeling) (Figure 7B), with variation between
different tumor nodules both in the proportion of posi-
tive cells and the intensity of labeling. There was faint
background labeling of bronchiolar cells and ma-
crophages in some sections. The variable intensity of
labeling between different tumor nodules remained con-
sistent even when applying different concentrations of
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Figure 7 JSRV-infected lung slice cells are positive for P-Akt and either positive or negative for P-ERK1/2 by IHC. Serial sections were
labeled with antibodies against JSRV SU, P-Akt and P-ERK1/2. A-C) OPA-N; D-F) JSRV-infected lung slice (16 dpi); G-I) JSRV-infected lung slice
(20 dpi); J-L) JSRV-ΔRT-treated lung slice (16 dpi). Note consistent co-labeling of P-Akt and SU positive cells compared to inconsistent labeling of
P-ERK1/2 for OPA-N and JSRV-infected lung slices and lack of labeling in JSRV-ΔRT-treated lung slice. Each scale bar is representative for the
whole row.
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due to limiting amounts of primary antibody but most
likely reflects different concentrations of P-Akt present
within different tumor cells. On JSRV-infected lung
slices, IHC of serial sections showed that SU-positive cells
co-aligned with strong labeling for P-Akt (Figure 7D, E, G,
and H). In contrast, lung slices infected with JSRV-ΔRT
showed P-Akt labeling only in occasional interstitial
cells (Figure 7K).Labeling of OPA-N lung sections for P-ERK1/2 iden-
tified positive tumor cells in 11 of 12 cases analyzed
(Figure 7C) and was localized either to the nucleus alone
or to the nucleus and cytoplasm. The proportion of
tumor cells labeling positively for P-ERK1/2 varied be-
tween individual nodules in the same section from none
to a low proportion (<10%) in most nodules, through to
100% of tumor cells in some nodules. The intensity of
labeling ranged from weak to very strong. In addition,
Cousens et al. Retrovirology  (2015) 12:31 Page 9 of 16some labeling was observed in endothelial cells, some
elongated interstitial cells in bronchial areas, consistent
with fibroblasts, and in some isolated bronchiolar
epithelial cells (not shown). In comparison, in JSRV-
infected lung slices SU-positive cells aligned with P-
ERK1/2 labeling cells in 18 of 41 of the SU-positive
“nodules” observed (Figure 7F, I). In uninfected and
JSRV-ΔRT-infected lung slices the majority of sections
were completely negative for P-ERK1/2 (Figure 7L).
Rarely, some interstitial cells were positive for P-ERK1/2
in both cytoplasmic and nuclear compartments (not
shown), and in one lung slice a few bronchiolar ciliated
epithelial cells were labeled but there was no labeling of
alveolar epithelial cells (not shown). Taken together,
these data indicate that JSRV-infected cells in lung slices
exhibit increased proliferation and activation of Akt and
ERK1/2, which closely resembles the phenotype of OPA
tumor cells in vivo.
Effect of age of donor animal on JSRV infection of lung
slices
The large variability in efficiency of JSRV infection in lung
slices led us to ask whether the developmental stage of the
lung could influence susceptibility to JSRV infection in
this ex vivo culture system, as an age-dependent effect in
the development of OPA in experimentally infected sheep
has been demonstrated previously [35]. Lung slices were
prepared from 3 animals of each of 4 age groups: pre-
term (1 week prior to expected parturition), new-born
(1–5 days old) and nine month old lambs, and adults (2–
10 years) and infected with JSRV or JSRV-ΔRT. RT-qPCR
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Figure 8 Replication of JSRV is more efficient in lung slices from youn
animals of different ages and the medium changed daily. The results show
presented as a percentage of the inoculum. The results represent data from
group. JSRV-ΔRT-infected controls are not shown as these were all negative
RNA throughout. The pre-term, new-born and 9 months groups show incr
low throughout.suggested that those from adult sheep produced less JSRV
than lung slices from the younger age groups (Figure 8).
Statistically significant differences were found between the
adult group and the new-born (p = 0.0253) and 9 months
(p < 0.0001) groups. The 9 months group was also statisti-
cally significantly different from the other groups; pre-
term p = 0.0014, new-born p = 0.0155.
Discussion
In this study we have demonstrated the ex vivo infection
of cultured ovine lung tissue with JSRV and the develop-
ment of small proliferating foci of cells with properties
similar to OPA lesions in vivo. Several features of this
system replicate the properties of natural and experi-
mental infections of lambs with JSRV, including the
phenotype of the target cell and the activation of Akt
and ERK1/2 signaling pathways (IHC data is summa-
rized in Table 2). The similarity of cells in JSRV-infected
foci in lung slices with those found in OPA in vivo sug-
gests that they may represent early tumors. However,
further studies are necessary to establish the tumorigenic
nature of the cells; for example, by formation of tumors
after transplantation into athymic nude mice as was
demonstrated for OPA cells derived from clinical cases
[36,37]. Nevertheless, we propose that lung slice infec-
tion represents an authentic in vitro model for studying
the early events of JSRV infection and transformation.
Previous in vitro systems for studying JSRV
Previous in vitro studies on JSRV have been limited by
the lack of a permissive cell line that can support effi-
cient virus replication. One reason for this is that the9 months adult
roup
4 dpi
8 dpi
12 dpi
16 dpi
ger sheep. JSRV was added to lung slices obtained from donor
JSRV RNA content of 24 h supernatants estimated by RT-qPCR and
pools of 4 lung slices in each of 3 replicate experiments for each age
after d 4. Control lung slices without virus were negative for JSRV
easing values with greater dpi, whilst the adult group remains
Table 2 Summary of IHC labeling of JSRV-infected cells in lung tissue samples from natural cases of OPA (OPA-N)
compared with JSRV infected and uninfected ovine lung or lung slices
Antibody target antigen Uninfected lung or lung slices Tumor cells (OPA-N) JSRV-positive lung slice cells
Cytokeratin Epithelial cells Positive Positive
JSRV SU Negative Positive Positive
Club cell specific
protein (CCSP)
Club cells in bronchial and bronchiolar epithelium Negative Negative
DC-LAMP Type II pneumocytes Mostly positive Mild to intense Mostly positive Mild to intense
Ki-67 Very few cells in lung except macrophages. In lung
slice, cells around edges
A few positive cells Many positive cells
Phospho-Akt (Ser473) Bronchiolar epithelial cells and some macrophages 50-100% positive Mild to intense 6/6 lung slices positive intense
Phospho-ERK1/2
(Thr202/Tyr204)
Endothelial cells, some fibroblasts, some
bronchiolar cells
All samples positive. Individual OPA
nodules varied from mild to intense
3/6 lung slices positive mild
Normal rabbit serum Negative Negative Negative
Mouse IgG Negative Negative Negative
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from the JSRV LTR, which requires transcription factors
that are preferentially expressed in type II alveolar pneu-
mocytes and bronchiolar club cells [38]. Attempts to in-
fect ovine cell lines with JSRV have achieved low levels
of replication and even in those cells JSRV could only be
detected by PCR for proviral DNA or by ultrasensitive
assays for reverse transcriptase activity, and only after
several passages of cells [39]. A further difficulty is that
primary type II pneumocytes and club cells do not main-
tain their differentiated phenotype when cultured as
monolayers on a plastic substrate [40]. This altered dif-
ferentiation state in monolayer culture is mirrored by
OPA tumor cells, which stop producing JSRV after a
relatively low number of passages in vitro [41]. Interest-
ingly, the expression of JSRV and of surfactant proteins
can be reactivated by growing OPA tumor cells in a 3D
culture system as spheres of polarized cells [42] and the
differentiated phenotype of primary ovine lung cells can
be prolonged for several passages in culture by growth
on a 3D matrix [25]. These findings demonstrate that
polarization of epithelial cells is important for maintain-
ing their differentiated phenotype in vitro. Because JSRV
replication depends on this differentiated state, 2D cul-
tures are of limited usefulness for studying JSRV infection.
Additionally, it is well established that tissue architecture
and interactions with other cell types have a significant ef-
fect on the way cells respond to infection or external sig-
nals (reviewed by [43]). Such responses may include
intracellular signaling pathways activated by JSRV Env and
in this respect it is notable that previous studies have
shown that the signaling pathways activated by JSRV in
cell lines differ depending on the cell line used [13,44] and
on whether the cells are grown in monolayer or 3D cul-
ture. By providing a source of stably differentiated type IIpneumocytes, together with other cell types in the lung
parenchyma, the lung slice culture system described here
provides an ideal platform for studying the interaction of
JSRV and its host cell in vitro and is likely to more accur-
ately represent the pathways activated in natural tumors
than studies in cell monolayers. Furthermore, the lung
slice system allows very early events in infection to be
studied in vitro. Such studies are challenging in vivo due
to difficulty of finding small infected foci within the large
volume of the lung. Moreover, the lung slice system per-
mits many replicate slices to be prepared from a single
animal, thereby reducing the number of animals required
compared to in vivo studies.
Replication of JSRV
Evidence that JSRV is able to infect and replicate in
sheep lung slice cultures was provided by the detection
of JSRV RNA in the supernatants of lung slices (Figure 2)
and by the appearance of JSRV SU-positive cells de-
tected by IHC. In most infected slices, JSRV production
was maintained and increased up to 16 or 20 days in
culture at which point the experiments were terminated.
The increase in the number of SU-positive groups of
cells over time, in addition to expansion of the number
of positive cells per group, suggests that additional
rounds of infection occurred in the lung slices secondary
to the primary inoculum. This is supported by the obser-
vation that JSRV released by infected lung slices is infec-
tious (Figure 3). However, we cannot rule out that cells
infected from the inoculum may have become SU-
positive at different rates, nor that infected cells may
have migrated to form new foci within the lung slices.
Although this system clearly provides a valuable plat-
form for studying JSRV, it was notable that virus produc-
tion in lung slices was highly variable, both between
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from the same lung. The low amount of viral RNA in
some lung slice supernatants approached the limit of
sensitivity of the RT-qPCR, which likely contributed to
the variability of the amount of virus detected (Figure 2)
[45]. However, the variation between replicate lung slices
was also evident from IHC labeling which, although not
quantitative, showed that some lung slices had many
SU-positive cells whereas others from the same donor
lung infected at the same time with the same JSRV virus
stock had few or none. There is, of course, natural vari-
ability in the precise numbers of different cell types be-
tween each individual lung slice; for example, the
proportion of alveoli compared to conducting airways is
different in each slice and this may, to some degree, ex-
plain the variability of infection observed. Future studies
will examine the variable infectivity of JSRV in lung
slices further, with the aim of increasing the reproduci-
bility of the system.
Identity of cell types infected with JSRV
An important factor determining JSRV infection in lung
tissue is the availability of appropriate target cells. The
identity of cell types infected and transformed by JSRV
is of great interest as they may be relevant to parallel
studies in mice and humans focused on identification of
the cells of origin in lung cancer [46]. Here, we focused
only on those cells that expressed JSRV SU protein de-
tectable by IHC. We recognize that JSRV may infect
some cells in lung tissue non-productively, for example
where the virus enters and integrates but where expres-
sion of viral proteins does not occur. It is conceivable
that such cells may act as a latent reservoir of infection
in infected sheep but for the purposes of this study we
regard them as irrelevant to pathogenesis.
Early studies on natural OPA indicated that the tumor
derives from type II pneumocytes in alveoli and, less
commonly, from bronchiolar club cells. This conclusion
was based on ultrastructural studies showing viral parti-
cles in cells [47,48] and immunohistochemical analysis
that suggested the majority of OPA tumor cells express
SP-C and a minority express CCSP [30].
More recent work on natural and experimentally-
derived OPA tumors has used multi-colored immu-
nofluorescence and IHC to identify the phenotype of
JSRV-positive cells more definitively. These studies show
clearly that the large majority of JSRV-positive cells
within OPA tumors co-express SP-C, indicating that
they are cells of the type II pneumocyte lineage [18,19,22].
However, some of these studies also identified CCSP and
JSRV Env double-positive cells either in natural tumors
[22] or as solitary cells in experimentally-infected lambs
10 dpi [18], indicating that ovine club cells can also be in-
fected by JSRV and express the viral oncoprotein. Thesedata confirm that transformation occurs primarily in SPC-
positive cells in the type II pneumocyte lineage, whereas
JSRV infection of club cells may contribute a relatively
minor part to tumor growth.
Here, we investigated which cell types are infected by
JSRV in cultured lung slices and how this compares with
in vivo infection. Using IHC labeling of serial sections,
we found that groups of cells expressing JSRV also
expressed markers of type II pneumocytes. Similar label-
ing was found in OPA-N where OPA tumor cells labeled
positively for JSRV SU, cytokeratin, and DC- LAMP. In
contrast, we did not find OPA-N tumor cells that were
positive for CCSP. Similarly, JSRV-infected cells in cul-
tured lung slices also showed no evidence for expression
of CCSP. The localization of JSRV infection to the same
cell type in tumors and cultured lung slices further
strengthens the utility of this ex vivo system as a model
for OPA.
In common with most other retroviruses, JSRV is able
to infect dividing cells much more efficiently than non-
dividing cells [19,49]. Therefore, the abundance of divid-
ing type II pneumocytes is likely to be a major determin-
ant of the ability of the virus to infect and replicate in
lung tissue, both in vivo and in vitro. Previous work
using experimentally-infected lambs has demonstrated
that younger animals are more susceptible to infection
and disease progression and have a shorter incubation
period than older animals [35]. As no significant adap-
tive immune response is raised against JSRV in infected
sheep, it was hypothesized that the different susceptibil-
ity in vivo may instead be due to the availability of target
cells which may be age-dependent. There is an increase
in the proportion of type II pneumocytes during the
large increase in lung volume and gas exchange surface
area in the first weeks of life [50,51] and although adult
sheep appear refractory to JSRV infection and tumor de-
velopment, they become susceptible following experi-
mental lung injury, which induces tissue repair and
increased cell division of type II pneumocytes [19]. It
has been suggested [19,21] that in naturally infected
sheep, lung repair in response to injury, for example, by
bacterial infection, may be important to allow JSRV to
move from cells of the lymphoreticular system where
replication is very low into the target cells in lung for
JSRV transformation and replication.
Our data from lung slice infections show a similar
trend to in vivo studies, in that lung slices established
from adult sheep appeared to be less susceptible to JSRV
infection in vitro than slices taken from lambs (Figure 8).
This is most likely to be a reflection of the abundance of
suitable target cells, (dividing type II pneumocytes), but
we cannot rule out that there may also be additional
age-related host differences that influence the ability of
JSRV to infect and replicate such as the expression of
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munity. Further studies are needed to examine this
question quantitatively. Nevertheless, the available data
indicate that to have the best chance of establishing
JSRV infection in lung slices, the use of lung tissue from
younger sheep is preferable.
Transformation by JSRV
Previous studies have demonstrated that JSRV oncogen-
esis is mediated by the viral Env protein which activates
protein kinase signaling pathways involved in transform-
ation [13]. In the present study, we found that tumor
cells in OPA-N and groups of cells expressing JSRV in
infected lung slices had a higher proportion of proliferat-
ing cells than uninfected lung or lung slices, as deter-
mined by Ki-67 labeling (Figure 6). This suggests that
JSRV Env expression in lung slices can stimulate prolif-
eration as it does in naturally infected lung [17] and in-
dicates that the lung slice model can be used to study
mechanisms of JSRV transformation in vitro.
The precise mechanism by which JSRV Env drives
transformation is unclear, but it is thought to activate a
number of cell signaling pathways that control cell
growth and differentiation. As noted above, the specific
pathways activated depend on the model used [13]. To
have value as an in vitro model, JSRV should activate the
same signaling pathways in cultured lung slices as it
does in natural tumors. Here, we examined activation of
Akt and ERK1/2 (MAPK p42/p44) as these pathways
have been identified in most previous studies of trans-
formation with JSRV and are also important in human
lung adenocarcinoma [13,52,53].
Dysregulation of Akt signaling pathways is common to
many cancers [54,55]. Phosphorylation (activation) of
Akt allows it to dissociate from the plasma membrane
and move to the cytoplasm or nucleus where it can acti-
vate downstream pathways involved in cell growth, div-
ision, survival, and metastasis [33,34]. Our IHC analysis
indicated that JSRV-infected cells in OPA-N and in lung
slices labeled positively for P-Akt (Figure 7). Therefore,
in vivo and in vitro, JSRV infection correlates with the
presence of P-Akt. This finding is in agreement with
studies on isolated OPA tumor cells grown in 3D culture
where Akt signaling was reported to be dysregulated
[56]. However, our finding that OPA tumors are positive
for P-Akt is in contrast to a previous study which re-
ported that OPA tumors do not express activated Akt
[57]. The reason for this apparent discrepancy is unclear
as the same commercial antibody was used here as in
that study.
ERK1/2 activation has been described in natural and
experimentally derived OPA tumor tissue [44,58] and in
OPA-derived tumor cell lines (Maeda and Fan unpub-
lished, cited in [44]). Our data from JSRV-infected lungslices suggest that activated ERK1/2 is present in some
JSRV-infected cells but that it is found less consistently
than P-Akt. It is possible that activation of the ERK1/2
pathway may occur later in transformation than Akt ac-
tivation. Alternatively, the detection of P-ERK1/2 may be
dependent on whether inhibitory regulatory pathways,
such as MAPK p38, are also active, as these have also
been reported to be activated by JSRV Env in cell line
studies [44]. While further analysis is necessary, it ap-
pears likely that additional pathways may be active in
established tumors compared to “new” infections or that
factors present in vivo but not in vitro result in increased
P-ERK1/2. Such factors include the presence of infiltrat-
ing myeloid cells, which are a key feature of OPA-N. In
many other cancers, tumor-associated macrophages and
neutrophils have important roles both in modulating
tumor cell growth and in potentiating the local anti-
tumor immune response [59]. While infiltrating cells are
not present in lung slices as these are derived from
healthy sheep, it would be interesting to collect these, by
broncho-alveolar lavage, from OPA positive sheep and
introduce them during the culture period to examine
their effect on infection and transformation. Thus the
lung slice model described here provides an ideal plat-
form for future studies to dissect the temporal changes
in pathway signaling and to examine other aspects of
JSRV infection and transformation.
Conclusions
We have shown that JSRV infects type II pneumocytes
in ovine lung slice cultures resulting in the production
of infectious virus particles and the activation of signal-
ing pathways associated with cell proliferation. Collect-
ively, these data demonstrate that JSRV infection of lung
slices cultured ex vivo reproduces many of the features
of JSRV infection of the ovine lung in vivo. This model
therefore provides a tractable in vitro system for studies
on JSRV replication and pathogenesis that will permit
detailed dissection of the early molecular events occur-
ring in JSRV-induced oncogenesis. Furthermore, the
availability of the lung slice system will further strengthen
the utility of OPA as a model for human lung adenocarcin-
oma. Finally, we note that the lung slice system could be
utilized for studying the effects of other oncogenes known
to be important in lung cancer such as mutated KRAS and
EGFR [53,60] and may also find application in the in vitro
evaluation of cancer therapeutics.
Methods
Animals
All animal work was performed at the Moredun Re-
search Institute in accordance with local ethics commit-
tee approval and UK Home Office regulations. Tissue
slices of normal ovine lung were prepared from lungs
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negative control animals in other experiments or ani-
mals culled as part of the normal management of our
high health status flock. Tissue slices of OPA lung tumor
were prepared also from natural cases of OPA (OPA-N)
that were donated by farmers and brought to the More-
dun Research Institute for post-mortem examination
and definitive diagnosis. Experimentally-induced cases of
OPA (OPA-E), used for comparison by identical immu-
nohistochemistry (see below), were from archived for-
malin fixed paraffin-wax embedded lung samples from
previous studies [18].
Preparation, culture and JSRV infection of ovine lung
slices
Animals were killed by captive bolt followed by immedi-
ate exsanguination. Lungs were removed whole along
with the trachea and heart immediately after death.
Using a 50 ml syringe, low melting point agarose (Sigma
type IX-A, 2% in Hank’s Balanced Salt Solution (HBSS;
5.4 mM KCl, 0.44 mM KH2PO4, 4 mM NaHCO3,
0.14 M NaCl, 3.4 mM NaH2PO4, 5.6 mM D-Glucose)),
at 37°C was introduced via a mainstem bronchus to a
whole lung (fetuses and lambs) or a single lung lobe
(adult animals; right cranial or right middle), until mod-
erate expansion was achieved. The agarose-infused lung/
lobe was clamped off at the primary bronchus, dissected
away from the rest of the lung and placed immediately
into HBSS on ice for 1 hour. A Krumdieck tissue slicer
(Alabama Research and Development, Munford, AL)
was used to cut slices of lung parenchyma approximately
300 μm thick and 8 mm in diameter. These were washed
5 times with lung slice wash medium (LSWM; DMEM,
50 U/ml penicillin/streptomycin, 4 mM L-glutamine,
0.2 μg/ml Gentamicin, 1.25 μg/ml Amphotericin B (all
Sigma)) and transferred into individual wells of a 24-well
tissue culture plate containing 0.3 ml per well of epithelial
cell medium (ECM; Quantum 286 (PAA Laboratories
Ltd), 50 U/ml penicillin/streptomycin, 4 mM L-glutamine,
0.2 μg/ml gentamicin, 1.25 μg/ml amphotericin, 5 ng/ml
recombinant human hepatocyte growth factor, 10 ng/ml
recombinant human keratinocyte growth factor, 10 μM
8-bromo-adenosine 3′,5′-cyclic monophosphate, 100 μM
3-isobutyl-1-methylxanthine, 100 nM dexamethasone
(all Sigma)). Control wells containing no lung slice (NLS)
were also included on each plate. Lung tumor slices were
prepared as for lung tissue except that the OPA-affected
tissue was sufficiently dense that it did not require
addition of agarose prior to cutting.
The plates were incubated in a humidified incubator at
39°C, 5% CO2 on an inclined rotator (Alabama Research
and Development, Munford, AL) set at 1 revolution per
minute (rpm). After 24 hours, the lung slices and NLS
wells were washed three times with 0.5 ml LSWM perwell. To each well was added 150 μL of ECM containing
8 μg/ml polybrene (Sigma) and approximately 6 × 106
RNA copies per ml of JSRV (JSRV or JSRV-ΔRT, see
below) and incubated at 39°C, 5% CO2, 1 rpm for 2 hours
when an additional 150 μl of ECM was added. As there
is no permissive cell line available for JSRV, infectious
titers cannot be determined, therefore the RNA copy
number of JSRV and JSRV-ΔRT in the inocula was esti-
mated as described previously [61]. Virus was removed
after a total of 24 hours and the wells were washed 3
times with LSWM before adding 300 μl of ECM.
Medium was harvested and replaced every 24–36 hours
thereafter. A further control of 4 lung slices without
JSRV challenge was included in each 24-well plate.
At 4 day intervals four lung slices each from the unin-
fected, JSRV-infected or JSRV-ΔRT-treated groups were
collected and fixed in 10% buffered neutral formalin for
subsequent immunohistochemistry (IHC). Also, at each
time point lung slice supernatant (i.e., the spent
medium) from 24 hours of culture was retained; super-
natants were pooled from 4 wells and centrifuged at
12,000 ×g for 2 minutes to remove cells and cell debris
before aliquoting and storing at −80°C.
For three lung slice experiments, supernatants from
the JSRV-infected or JSRV-ΔRT-treated lung slices were
collected daily from 11 to 16 dpi and were prepared as
above and stored at −80°C. These were thawed, pooled
and concentrated by centrifugation at 50,000 × g for
2 hours and the pellet was resuspended in 1/40 volume
of ECM. In duplicate experiments these concentrated
supernatants were used to infect lung slices essentially
as described above except that 50 μl was used as
inoculum per well (viral RNA copy number was not
determined).
Virus production
Infectious wild-type JSRV was produced by in vitro
transfection of 293 T cells with plasmid pCMV2JS21 as
described [18]. Culture supernatants were harvested 48
and 72 hours post-transfection, filtered (0.45 μm), ali-
quoted and stored at −80°C for use in the entire series
of experiments. As a negative control virus, we gener-
ated a replication-defective molecular clone of JSRV that
contains a mutation in the active site of reverse transcript-
ase (YMDD to AAGA). This mutant (JSRV-ΔRT) was
generated by PCR of pCMV2JS21 using 5′-phosphorylated
primers 5′-GCCGCTATATTACTAGCTCATGCTG-3′
and 5-GCCGGCATGAACCAAGTATAGCTGAGG-3′
with the KOD High Fidelity polymerase system (Merck)
as recommended by the manufacturers. The resulting
11.5 kb product was re-circularized by ligation and used
to transform E. coli XL10-Gold cells (Stratagene). DNA
sequencing of the resulting clones was performed to con-
firm the desired mutation and the absence of polymerase
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as wild type JSRV.
Cell viability analysis of lung slices
Visualization of active coordinated movement of cilia on
the ciliated respiratory epithelial cells was used as an in-
dicator of the viability of the lung slices [27]. In addition,
viability of cells was evaluated on some of the lung slices
by treatment with LIVE/DEAD reduced biohazard via-
bility/cytotoxicity assay reagents (Molecular Probes,
768736). The stock reagents (SYTO 10 green fluorescent
nucleic acid stain and DEAD Red ethidium homodimer-
2 nucleic acid stain) were diluted to their final working
concentrations (1:500) in HBSS. Each slice was incu-
bated in 200 μl of solution at room temperature for
30 minutes. As a positive control for the dead stain, one
set of lung slices was treated with 1% Triton X-100 for
15 minutes prior to staining and subsequent imaging.
Reverse transcriptase-quantitative PCR (RT-qPCR)
RT-qPCR was performed as described previously [61].
Briefly, RNA was extracted from 140 μl of lung slice
supernatant (pooled from 4 wells which each contained
a lung slice) using the QIAmp viral RNA mini kit (QIA-
gen) exactly as manufacturer’s instructions and eluted in
50 μl of the buffer provided. Contaminating DNA was
removed using the TURBO DNA-free kit (Ambion)
prior to RT-qPCR by adding 1.5 μl 10× DNase buffer,
1 μl water and 0.5 μl TURBO DNase to 12 μl of RNA
and incubating at 37°C for 30 minutes. DNAse inactiva-
tion reagent (1 μl; Ambion) was added, vortexed several
times and then centrifuged. 5 μl of the supernatant was
used in duplicate RT-qPCR reactions. LTR primers,
fluorescent labeled probe, and RT-qPCR conditions were
as described previously [61].
Stored aliquots of day 4 supernatant from a lung
tumor slice culture were used as an extraction positive
control. An RNA standard curve was generated as de-
scribed previously [61]. The concentration of virus in
the supernatants was expressed relative to the concen-
tration of virus in the inoculum as EΔCt where E is the
amplification efficiency calculated from the slope of the
standard curve according to the formula: E = 10(−1/slope)
and ΔCt is the difference between the Ct values for the
d0 and dn supernatants.
Statistical analysis
To statistically analyze the differences between lung
slices from animals of different ages a linear model was
fitted using generalized least squares (GLS) by REML
allowing heterogeneous group variances. The model was
applied on the rank-based inverse normal transformation
of the data where age group and dpi were, respectively,
main effect and co-variate. For pairwise comparisonmultiple group comparisons were arranged from the fit-
ted model and the resulting p-values were adjusted to
control for the false discovery rate.
Immunohistochemistry
Lung tissue and lung slices were fixed in 10% neutral buff-
ered formalin, processed routinely by dehydrating through
graded alcohols, embedded in paraffin wax, sectioned
(5 μm) and mounted on Superfrost™ glass microscope
slides (Menzel-Gläser, Braunschweig, Germany). IHC was
carried out as described previously [18]. The optimal con-
centration of each primary antibody was ascertained using
appropriate positive control tissue as listed in Table 1.
Negative controls for IHC were performed by substitution
of the primary antibody with purified mouse IgG, rabbit
IgG, or normal rabbit serum as appropriate. IHC was
performed on sections of lung that contained areas
of OPA identified by standard histological examination
(hematoxylin and eosin (HE) staining). The sections were
from six sheep that were naturally affected and had ad-
vanced clinical signs of OPA and six that had been ex-
perimentally infected with JSRV and had early stage
asymptomatic OPA, where tumors were visible histologi-
cally but were not sufficiently advanced to induce clinical
signs. IHC was performed on sections of OPA-N and
OPA-E lung tissue, lung slices and lung tumor slices. For
IHC of consecutive serial sections with different anti-
bodies (Table 1) JSRV-infected lung slices with more than
3 groups of SU-positive cells were selected; these lung
slices had been prepared from 6 different animals of dif-
ferent ages (5d to 10 years) and were harvested for IHC at
16 or 20 dpi. The equivalent JSRV-ΔRT-treated lung slices
were used as negative controls.
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